Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Avian ("Bird") Flu Stocks -- Ignore unavailable to you. Want to Upgrade?

To: Becky who wrote (157)	11/6/2005 6:13:12 PM
From: MJ	Respond to of 428

Checked out the list of Avian stocks. Vicl was the only one down on Friday. The others were all up. NVAX is interesting also from the position of the Estrasorb cream. Estrasorb was withdrawn as I understand back in 2002 but then gained FDA approval. The success in stopping hot flashes for women runs fairly high. NVAX has come to people's attention because of vaccine potential but the Estrasorb and the testosterone developed for women is of interest. Sucess rate on Estrasorb and hot flashes is very good------Baby boom women want to live active lives so appears NVAX has other things to market other than vaccines. Technically it is at a bottom-----but then one has to ask can that bottom be extended or is it ready to move up. If not then short term it is a trading stock. Thoughts?? mj